BOGAZZI, FAUSTO
 Distribuzione geografica
Continente #
NA - Nord America 11.798
EU - Europa 4.193
AS - Asia 1.977
AF - Africa 208
OC - Oceania 13
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.206
Nazione #
US - Stati Uniti d'America 11.479
IT - Italia 1.341
CN - Cina 915
SE - Svezia 823
BG - Bulgaria 548
DE - Germania 518
SG - Singapore 387
CA - Canada 317
TR - Turchia 277
UA - Ucraina 248
GB - Regno Unito 212
FI - Finlandia 196
VN - Vietnam 184
HK - Hong Kong 152
SN - Senegal 115
CH - Svizzera 95
RU - Federazione Russa 74
CI - Costa d'Avorio 70
IN - India 34
FR - Francia 33
BE - Belgio 26
AT - Austria 23
GR - Grecia 16
NL - Olanda 16
AU - Australia 10
BJ - Benin 8
BR - Brasile 8
IE - Irlanda 8
EG - Egitto 6
MY - Malesia 6
NG - Nigeria 6
EU - Europa 5
KR - Corea 4
ES - Italia 3
IL - Israele 3
JP - Giappone 3
NZ - Nuova Zelanda 3
CO - Colombia 2
CZ - Repubblica Ceca 2
IR - Iran 2
MX - Messico 2
PH - Filippine 2
PL - Polonia 2
RO - Romania 2
TW - Taiwan 2
ZA - Sudafrica 2
AR - Argentina 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
DK - Danimarca 1
EC - Ecuador 1
HR - Croazia 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
Totale 18.206
Città #
Woodbridge 1.765
Fairfield 1.432
Ann Arbor 976
Chandler 963
Houston 948
Ashburn 713
Seattle 604
Milan 578
Sofia 546
Cambridge 523
Wilmington 468
Jacksonville 354
Beijing 340
New York 314
Ottawa 302
Izmir 267
Boardman 237
Princeton 218
Lawrence 207
Medford 188
Nanjing 172
Singapore 158
Des Moines 136
Dakar 115
Bern 95
Dearborn 87
Serra 87
Dong Ket 85
Bremen 84
Florence 82
Nanchang 79
Jüchen 77
Abidjan 70
San Diego 70
Rome 56
Lancaster 48
Hong Kong 47
Kunming 46
Boulder 38
Pisa 37
Frankfurt am Main 35
Hebei 35
Tianjin 34
Changsha 33
Redwood City 33
Shenyang 29
Jiaxing 26
Washington 26
Auburn Hills 24
Falls Church 24
Ogden 24
Detroit 23
Hangzhou 22
Los Angeles 22
Brussels 21
Hefei 20
Marseille 20
Vienna 19
Norwalk 18
Pune 18
Jinan 15
Zhengzhou 14
Düsseldorf 13
London 13
Dallas 12
Orange 12
Sacile 11
Cotonou 8
Guangzhou 8
Nürnberg 8
Seacroft 8
Phoenix 7
Tappahannock 7
Chicago 6
Kuala Lumpur 6
Lagos 6
Central District 5
Council Bluffs 5
Curitiba 5
Istanbul 5
Kocaeli 5
Redmond 5
Sydney 5
Toronto 5
Waanrode 5
Cairo 4
Changchun 4
Costa Mesa 4
Dublin 4
Grafing 4
Indiana 4
Livorno 4
Moscow 4
Simi Valley 4
Venturina 4
Verona 4
Edinburgh 3
Empoli 3
Kent 3
Madrid 3
Totale 14.373
Nome #
Somatostatin analogues do not affect calcium metabolism in patients with acromegaly and primary hyperparathyroidism due to MEN 1-Like syndrome 202
uptake of amiodarone by thyroidal and non-thyroidal cell lines 163
Total thyroidectomy in patients with amiodarone-induced thyrotoxicosis and severe left ventricular systolic dysfunction. 159
The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type 151
Amiodarone-induced thyrotoxicosis: something new to refine the initial diagnosis? 150
FT-IR Microspectroscopy application in cardiac Hypertrophy 149
Glucocorticoid response in amiodarone-induced thyrotoxicosis due to destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations 147
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 147
Effects of Amiodarone, Thyroid Hormones and CYP2C9 and VKORC1 Polymorphisms on Warfarin Metabolism: A Review of the Literature. 147
AMIODARONE-INDUCED THYROTOXICOSIS AND THYROID STORM 146
Growth Hormone Is Necessary for the p53-Mediated, Obesity-Induced Insulin Resistance in Male C57BL/6J × CBA Mice 144
Amiodarone-Induced Thyrotoxicosis 143
Primary hyperparathyroidism is associated with marked impairment of GH response to acylated ghrelin 139
More on smoking habits and Graves' ophthalmopathy 138
Bone and joint alterations in acromegaly 137
Diagnosis and management of amiodarone-induced thyrotoxicosis: similarities and differences between North American and European thyroidologists 135
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 135
Large vestibular aqueduct syndrome: audiological, radiological, clinical, and genetic features 135
REGULATION OF CARDIAC FATTY ACID METABOLISM IN TRANSGENIC MICE OVEREXPRESSING BOVINE GROWTH HORMONE 134
IMPAIRED LEFT VENTRICULAR DIASTOLIC FUNCTION IN ACROMEGALIC PATIENTS WITHOUT CLINICAL SIGNS OF HEART FAILURE: A 2D STRAIN ECHOCARDIOGRAPHIC ANALYSIS 134
The mechanisms of nadroparin-mediated inhibition of proliferation of two human lung cancer cell lines 132
Graves' disease occurring after subacute thyroiditis: report of a case and review of the literature 130
The age of patients with thyrotoxicosis factitia in Italy from 1973 to 1996 130
Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study 127
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 127
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 124
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial 122
Lack of nocturnal serum thyrotropin surge after surgery 121
Adverse effects of thyroid hormone preparations and antithyroid drugs 121
Pendrin does not increase sulfate uptake in mammalian COS-7 cells 121
Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism 121
A novel mutation in the pendrin gene associated with the Pendred’s syndrome 121
Identification, treatment and management of cardiovascular risks in patients with acromegaly 120
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 120
Assessment of the awareness and management of sleep apnea syndrome in acromegaly. The COM.E.TA (Comorbidities Evaluation and Treatment in Acromegaly) Italian Study Group 118
Prevalence and functional significance of antipituitary antibodies in patients with autoimmune and non- autoimmune thyroid diseases 118
Prognostic factors for pancreatic neuroendocrine neoplasms (pNET) and the risk of small non-functioning pNET 118
Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Graves' disease 117
Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study 117
Glucocorticoid therapy of Graves' ophthalmopathy 115
Abnormal expression of PPAR gamma isoforms in the subcutaneos adipose tissue of patients with Cushing's disease 115
Serum Insulin-Like Growth Factor-1 Concentrations Are Reduced in Severely Obese Women and Raise After Weight Loss Induced by Laparoscopic Adjustable Gastric Banding 115
Long-Term outcome of patients with type 2 amiodarone induced thyrotoxicosis 114
The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells 113
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly 112
Mutations in the SLC26A4 (pendrin) gene in patients with sensorineural deafness and enlarged vestibular aqueduct 112
Surgical Treatment of Neuroendocrine Tumors of the Pancreas: Results and Prognostic Factors 111
Potassium perchlorate only temporarily restores euthyroidism in patients with amiodarone-induced hypothyroidism who continue amiodarone therapy 111
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis 110
Orbital radiotherapy in the treatment of endocrine ophthalmopathy: when and why 109
Graves' hyperthyroidism and ophthalmopathy associated with pemphigus vulgaris: onset of thyroid autoimmune disease during chronic low-dose glucocorticoid therapy 109
COMPARISON OF COLONOSCOPY AND FECAL OCCULT BLOOD TESTING AS A FIRST-LINE SCREENING OF COLONIC LESIONS IN PATIENTS WITH NEWLY DIAGNOSED ACROMEGALY 109
null 109
ACROSTUDY: the Italian experience 109
Prostate-specific antigen is increased in female patients with Cushing's disease 108
Proportion of type 1 and type 2 amiodarone-induced thyrotoxicosis has changed over a 27-year period in Italy 108
Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis 107
Studies on the occurrence of ophthalmopathy in Graves' disease 106
Ectopic Spleens in the Tail of the Pancreas Mimicking Multifocal Neuroendocrine Tumors in a Patient with History of Endocrine Neoplasia. A Case Report 106
A novel germline mutation in the aryl hydrocarbon receptor-interacting protein (Aip) gene in an Italian family with gigantism 106
Orbital irradiation in the treatment of Graves' ophthalmopathy 105
Early pre-clinical abnormalities of systolic strain and strain-rate in acromegalic heart: a color Doppler myocardial imaging study 105
Identification of factors affecting the response to glucocorticoids in patients with amiodarone-induced thyrotoxicosis 104
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 103
Cigarette smoking and the thyroid 102
Measurement of serum free thyroid hormone concentrations: an essential tool for the diagnosis of thyroid dysfunction 102
Surgical treatment of Graves' disease: subtotal or total thyroidectomy? 102
Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis 101
The beneficial effect of acromegaly control on blood pressure values in normotensive patients 100
Role of cytokines in the pathogenesis of the euthyroid sick syndrome 99
Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no? 98
Abnormal expression of PPAR gamma isoforms in the subcutaneous adipose tissue of patients with Cushing's disease 98
Diabetes mellitus induced by somatostatin analogue therapy is not permanent in acromegalic patients 98
Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study 97
Role of orbital radiotherapy in the treatment of Graves' ophthalmopathy 96
A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor 96
Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery 95
Apoptosis is reduced in the colonic mucosa of patients with acromegaly 94
null 94
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 94
Aberrant Expression of FSH Receptor in Pancreatic Neuroendocrine Tumors 93
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography 93
null 93
VITAMIN D STATUS MAY CONTRIBUTE TO SERUM IGF1 CONCENTRATIONS IN HEALTHY SUBJECTS 92
Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies 92
Growth hormone secretion in primary and secondary hyperparathyroidism 91
Tumor Infiltrating Lymphocytes But Not Serum Pituitary Antibodies Are Associated with Poor Clinical Outcome after Surgery in Patients with Pituitary Adenoma 91
Lower Prolactin Levels During Cabergoline Treatment are Associated to Tumor Shrinkage in Prolactin Secreting Pituitary Adenoma. 91
Approach to the patient with amiodarone-induced thyrotoxicosis 90
Analysis of voice in patients with untreated active acromegaly 90
Vitamin D status may contribute to serum insulin-like growth factor I concentrations in healthy subjects 90
Gestione clinica della tireopatia da amiodarone 90
Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy 89
[Amiodarone and the thyroid] 89
Orbital decompression for severe Graves' ophthalmopathy. Results of a three-wall operative technique 88
Identification, treatment and management of cardiovascular risks patients with acromegaly 88
Adjuvant effect of lithium on radioiodine treatment of hyperthyroidism 88
Serum prostate-specific antigen concentration is increased in acromegalic women 88
Pituary autoimmunity in patients with diabetes mellitus and other endocrine disorders 88
Submandibular salivary gland volume is increased in patients with acromegaly 87
Totale 11.358
Categoria #
all - tutte 46.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.808 0 0 0 252 383 420 458 311 379 254 280 71
2020/20211.473 166 76 114 65 144 79 109 157 117 113 101 232
2021/20222.170 25 89 30 153 482 300 35 102 170 68 107 609
2022/20232.560 324 237 150 304 285 355 9 237 507 7 120 25
2023/20242.165 303 272 334 162 331 369 73 63 24 15 39 180
2024/2025349 25 241 37 46 0 0 0 0 0 0 0 0
Totale 18.421